Aprea Therapeutics, Inc. - COM NEW (APRE)

Historical Portfolio Holders from Q1 2023 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
2M
Holdings value Q3 2024
$5.5M
Value change Q3 2024
-$431K
Grand Portfolio weight change Q3 2024
0%
Number of holders
20
Number of buys Q3 2024
5
Number of sells Q3 2024
-9
Average buys Q3 2024 %
0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 2M $5.5M -$431K $2.75 20
2024 Q2 2.08M $8.47M +$1.87M $4.07 26
2024 Q1 1.62M $10.8M +$4.97M $6.69 21
2023 Q4 926K $4.35M +$26.6K $4.70 19
2023 Q3 876K $3.66M -$19.5K $4.17 19
2023 Q2 881K $2.77M +$102K $3.15 17
2023 Q1 848K $3.77M +$3.77M $4.44 16